Acta Med. 2004, 47: 267-272

https://doi.org/10.14712/18059694.2018.103

Our Experience with Diagnostics of Congenital Disorders of Glycosylation

Ziad Albahria, Eliška Marklováa, Hubert Vaníčeka, Lenka Minxováa, Petr Dědeka, Sylva Skálováa, Marika Talábováb, Jaroslava Vávrovác, Eva Rencovád

aCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Paediatrics, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Neurology, Hradec Králové, Czech Republic
cCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Clinical Chemistry, Hradec Králové, Czech Republic
dCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Ophthalmology, Hradec Králové, Czech Republic

Received March 1, 2004
Accepted July 1, 2004

References

1. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 2001; 47(1):13–27.
2. Artuch R, Ferrer I, Pineda J et al. Western blotting with diaminobenzidine detection for the diagnosis of congenital disorders of glycosylation. J Neurosci Methods 2003; 125:167–71. <https://doi.org/10.1016/S0165-0270(03)00051-7>
3. Barnier A, Dupré T, Cuer M, Vuillaumier-Barrot S, Durand G, Seta N. Leukocyte phosphomannomutase activity in diagnosis of congenital disorder of glycosylation Ia. Clin Chem 2002; 48:934–6.
4. Beckman LE, Van Landeghem GF, Sikstrom C, Lundgren R, Beckman L. Protective effect of transferrin C3 in lung cancer? Oncology 1999; 56(4):328–31. <https://doi.org/10.1159/000011987>
5. Beutler E, Kuhl W. The diagnosis of the adult type of Gaucher’s disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. J Lab Clin Med 1970; 76:747–55.
6. de Jong G, van Noort WL, Feelders RA, de Jeu-Jaspars CM, van Eijk HG. Adaptation of transferrin protein and glycan synthesis. Clin Chim Acta 1992; 212(1–2):27–45. <https://doi.org/10.1016/0009-8981(92)90135-D>
7. de Koning TJ, Dorland L, van Diggelen OP et al. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun 1998; 245(1):38–42. <https://doi.org/10.1006/bbrc.1998.8385>
8. Gorg A, Weser J, Westermeier R et al. Isoelectric focusing with immobilized pH gradients for the analysis of transferrin (Tf) subtypes and variants. Hum Genet 1983; 64(3):222–6. <https://doi.org/10.1007/BF00279397>
9. Grünewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. Pediatr Res 2002; 52:618–24. <https://doi.org/10.1203/00006450-200211000-00003>
10. Jaeken J, Kint J, Spaapen L. Serum lysosomal enzyme abnormalities in galactosaemia. Lancet 1992; 340(8833):1472–3. <https://doi.org/10.1016/0140-6736(92)92664-2>
11. Jaeken J. Komrower Lecture. Congenital disorders of glycosylation (CDG): it’s all in it! J Inherit Metab Dis 2003; 26:99–118. <https://doi.org/10.1023/A:1024431131208>
12. Jeppsson JO, Franzen B. Typing of genetic variants of alpha 1-antitrypsin by electrofocusing. Clin Chem 1982; 28(1):219–25.
13. Kamboh MI, Ferrell RE. Human transferrin polymorphism (review). Hum Hered 1987; 37:65–81. <https://doi.org/10.1159/000153680>
14. Kano H, Kobayashi K, Herrmann R et al. Deficiency of a-dystroglycan in muscleeye- brain disease. Biochem Biophys Res Commun 2002; 291:1283–86. <https://doi.org/10.1006/bbrc.2002.6608>
15. Keir G, Winchester BG, Clayton P. Carbohydrate-deficient glycoprotein syndromes: inborn errors of protein glycosylation. Ann Clin Biochem 1999; 36:20–36. <https://doi.org/10.1177/000456329903600103>
16. Kim S, Westphal V, Srikrishna G et al. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie). J Clin Invest 2000; 105(2):191–8. <https://doi.org/10.1172/JCI7302> <PubMed>
17. Kleinert P, Kuster T, Durka S et al. Mass spectrometric analysis of human transferrin in different body fluids. Clin Chem Lab Med 2003; 41(12):1580–8. <https://doi.org/10.1515/CCLM.2003.241>
18. Kühnl P, Spielmann W. A third common allele in the transferrin system, TfC3, detected by isoelectric focusing. Hum Genet 1979; 50(2):193–8. <https://doi.org/10.1007/BF00390241>
19. Macchia PE, Harrison HH, Scherberg NH, Sunthornthepfvarakul T, Jaeken J, Refetoff S. Thyroid function tests and characterization of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type I. J Clin Endocrinol Metab 1995; 80:3744–9.
20. Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr 2003; 162:359–79.
21. Namekata K, Imagawa M, Terashi A, Ohta S, Oyama F, Ihara Y. Association of transferrin C2 allele with late-onset Alzheimer’s disease. Hum Genet 1997; 101(2):126–9. <https://doi.org/10.1007/s004390050600>
22. Niehues R, Hasilik M, Alton G et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 1998; 101:1414–20. <https://doi.org/10.1172/JCI2350> <PubMed>
23. van Noort WL, Jong G de, Eijk HG van. Ideale scheidingen kwantificering van sialo transferrinefracties in humaan serum. Tijdschr NVKC 1993; 18:43–45.
24. Pascali VL, Bravo E, Auconi P et al. Transferrin subtypes in cystic fibrosis. Eur J Pediatr 1984; 143(2):133–4. <https://doi.org/10.1007/BF00445801>
25. Petrén S, Vesterberg O. Separation of different forms of transferrin by isoelectric focusing to detect effects on the liver caused by xenobiotics. Electrophoresis 1989; 10(8–9):600–4. <https://doi.org/10.1002/elps.1150100812>
26. Roelandse FWC, van der Zwart N, Didden JH, van Loon J, Souverijn JHM. Detection of CSF leakage by isoelectric focusing on polyacrylamide gel, direct immunofixation of transferrins, and silver staining. Clin Chem 1998; 44:351–3.
27. Seta N, Barnier A, Hochedes F, Besnard MA, Durand G. Diagnostic value of Western blotting in carbohydrate deficient glycoprotein syndrome. Clin Chim Acta 1996; 254:131–40. <https://doi.org/10.1016/0009-8981(96)06379-6>
28. Stibler H, Holzpach U, Kristiansson B. Isoforms and levels of transferrin, antithrombin, α1-antitrypsin and thyroxine-binding globulin in 48 patients with carbohydrate- deficient glycoprotein syndrome type I. Scand J Clin Lab Invest 1998; 58:55–62. <https://doi.org/10.1080/00365519850186832>
29. Stibler H, Jaeken J, Kristiansson B. Biochemical characteristics and diagnosis of the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand 1991; 375 (Suppl 375):21–31. <https://doi.org/10.1111/j.1651-2227.1991.tb12025.x>
30. Van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate- deficient glycoprotein syndrome type I. FEBS Lett 1995; 377:318–20.
31. Wong CT, Saha N. Effects of transferrin genetic phenotypes on total iron-binding capacity. Acta Haematol 1986; 75(4):215–8. <https://doi.org/10.1159/000206128>
32. Wopereis S, Grünewald S, Morava E et al. Apolipoprotein C-III Isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin Chem 2003; 49:1839–45. <https://doi.org/10.1373/clinchem.2003.022541>
33. Wuyts B, Delanghe J R, Kasvosve I. Determination of carbohydrate-deficient transferrin using capillary zone electrophoresis. Clin Chim 2001; 47:247–255.
34. Yuasa I, Ohno K, Hashimoto K, Iijima K, Yamashita K, Takeshita K. Carbohydrate deficient glycoprotein syndrome: electrophoretic study of multiple serum glycoproteins. Brain Dev 1995; 17:13–9. <https://doi.org/10.1016/0387-7604(94)00099-J>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive